Therapeutics that only engage under desirable conditions enable safer treatment strategies.
Multiple combinations of engagers and agonists allow for an expandable array of potential targets.
Nature of our therapeutics allows for revisiting strategies previously deemed impossible by expanding the therapeutic index.
Strategies are not limited to specific ailments or locations and can be adapted for cancer, auto-immune, and other disease types.